Cell and Gene Therapy Biomanufacturing Market

shared a link

2023-06-20 09:41:45 - South Korea - Translate -

Cell and Gene Therapy Biomanufacturing Report - Insights, leading players, growth and Forecast to 2031

Cell and Gene Therapy Biomanufacturing Market was valued at $12.31 billion in 2022 and is anticipated to reach $29.76 billion by 2031, witnessing a CAGR of 10.31% during the forecast period 2022-2031.

Read detailed insights at: https://bisresearch.com/industry-report/cell-gene-therapy-biomanufacturing-market.html?utm_source=Tanzeel&utm_medium=organic&utm_campaign=tanzeel_organic

Cell and Gene Therapy Biomanufacturing Report - Insights, leading players, growth and Forecast to 2031 Cell and Gene Therapy Biomanufacturing Market was valued at $12.31 billion in 2022 and is anticipated to reach $29.76 billion by 2031, witnessing a CAGR of 10.31% during the forecast period 2022-2031. Read detailed insights at: https://bisresearch.com/industry-report/cell-gene-therapy-biomanufacturing-market.html?utm_source=Tanzeel&utm_medium=organic&utm_campaign=tanzeel_organic

BISRESEARCH.COM

Cell and Gene Therapy Biomanufacturing Market - A Global and Regional Analysis: Focus on Product Type, Application, Usage, End User, and Region - Analysis and Forecast, 2022-2031

The global cell and gene therapy biomanufacturing market is expected to reach $29.76 billion by 2031, growing at a CAGR of 10.31% during 2022-2031.

0 Comments 0 Shares 317 Views 0 Reviews